[Result of Panzytrat 25000 therapy following total gastrectomy].

Orv Hetil

III. Sebészeti Klinika, Semmelweis Orvostudományi Egyetem, Budapest.

Published: September 1999

Thirteen patients who had undergone total gastrectomy because of gastric cancer in 11 cases and gastric lymphoma in 2 cases (6 female, 7 male) at the 3rd Department of Surgery, Semmelweis University, Medical School have been followed up. The length of follow up period varied between 7.5 months and six years. Vitamin B12 substitution was applied in each case (300 micrograms/month). In 6 cases early temporary iron substitution was necessary. Regular pancreatic enzyme substitution (pancreatin) was used during meals in these patients. At the beginning Kreon (Chinoin) or Neo-Panpur (Egis) treatment was applied. Since April 1996 the patients have been treated by Panzytrat 25,000 (Knoll) which has higher enzyme content comparing with the previous ones. Following gastrectomy the digestion and absorption improved due to pancreatic enzyme substitution and the body weight increased. The serum albumin and cholesterol levels elevated significantly, while the serum uric acid levels did not changed. The iron absorption improved, patients did not require iron substitution later, except two cases. One of them needed transitoric and the other continuous iron substitution. Side effects were recorded in six cases. One of the 13 patients stopped application of Panzytrat 25,000 because of epigastric pain among other side effects (2 epigastric pain, 2 hyperuric state, 2 frequent discharge of stool) and returned to well tolerated Neo-Panpur.

Download full-text PDF

Source

Publication Analysis

Top Keywords

panzytrat 25000
12
iron substitution
12
pancreatic enzyme
8
enzyme substitution
8
absorption improved
8
side effects
8
epigastric pain
8
substitution
6
patients
5
cases
5

Similar Publications

Background: Pancreatic exocrine insufficiency (PEI) often occurs following pancreatic surgery.

Aim: To demonstrate the superior efficacy of pancreatin 25 000 minimicrospheres (Creon 25000 MMS; 9-15 capsules/day) over placebo in treating PEI after pancreatic resection.

Methods: A 1-week, double-blind, randomised, placebo-controlled, parallel-group, multicentre study with a 1-year, open-label extension (OLE).

View Article and Find Full Text PDF

In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.

Aliment Pharmacol Ther

February 2008

Laboratory of Enzymology at Interfaces and Physiology of Lipolysis, CNRS-UPR 9025-IBSM, Marseille, France.

Background: Various pancreatic enzyme preparations are used for the treatment of pancreatic insufficiency but their bioequivalence is often unknown.

Aim: To determine in vitro the pH-dependent release and acid resistance of enzymes from three commercially available pancreatin capsules, two containing enteric-coated (Creon 25000; Eurobiol 25000) and one uncoated (Eurobiol 12500) microspheres.

Methods: Dissolution experiments were performed at pH values ranging from 4.

View Article and Find Full Text PDF

[Result of Panzytrat 25000 therapy following total gastrectomy].

Orv Hetil

September 1999

III. Sebészeti Klinika, Semmelweis Orvostudományi Egyetem, Budapest.

Thirteen patients who had undergone total gastrectomy because of gastric cancer in 11 cases and gastric lymphoma in 2 cases (6 female, 7 male) at the 3rd Department of Surgery, Semmelweis University, Medical School have been followed up. The length of follow up period varied between 7.5 months and six years.

View Article and Find Full Text PDF

[Treatment of pancreatic insufficiency with a preparation containing high lipase activity].

Orv Hetil

March 1997

Fóvárosi Onkormányzat Szent Imre Kórház Budapest, II. Belgyógyaszati Osztály.

In vitro testing of lipase survival of Panzytrat 25,000 homogenized in Tris HCl buffer and Lundh meal stimulated gastric or duodenal contents demonstrated favorable stability of lipase of this new preparation in the protein and fat containing gastric and duodenal juices of patients with chronic pancreatitis. Later an open, intra-individually controlled study with two doses of Panzytrat 25000 (5 x 1 and 5 x 2 capsules/day) was performed in 10 patients with severe pancreatic steatorrhoea. A diet containing 70 g of fat/day was offered and the 3-day fat loss of collected stools was measured in the last 3 days of 5-day equilibration periods with and without replacement therapy.

View Article and Find Full Text PDF

Fibrosing colonopathy was first described in cystic fibrosis (CF) children in 1994. We have done a nested case-control study to identify possible associations with this condition. A case ascertainment within the UK CF population to identify any cases that occurred between January, 1984, and April, 1994, found 14 cases, all under 14 years and confirmed by independent histopathological review.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!